From the *TransVIHMI Unit, University of Montpellier, INSERM, IRD TransVIHMI, Montpellier, France
†Infectious Diseases, University of California San Francisco, California
‡Massachusetts General Hospital Department of Medicine
§Department of Innovation and New Technologies, Elizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland
¶Elizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland
‖Infectious Diseases, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
Accepted for publication June 22, 2021
The authors have no funding or conflicts of interest to disclose.
Dr. Anca Vasiliu and Dr. Rebecca A. Abelman contributed equally to the research.
Dr. Jennifer Cohn and Dr. Maryline Bonnet contributed equally to the coordination of the research.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (www.pidj.com).
Address correspondence to: Anca Vasiliu, MD, MPH, TransVIHMI Unit, University of Montpellier, 911 Avenue Agropolis, IRD UMI 233 TransVIHMI, Montpellier, France. E-mail: [email protected].